Digital healthcare, a globally booming market, has been catalyzed by the events of COVID-19. In Asia Pacific, in particular, a rapidly expanding population, an empowered and tech-savvy middle class and physician shortage has created the perfect conditions for digital health innovation.

A new era of digital healthcare innovation looms on the horizon where there is now greater imperative to develop future-proof digital health solutions and systems in a “next-generation” ecosystem that channels hybridity and multi-functionality.

Baker McKenzie’s newest report, Hyper-Hybridity: Defining a New Era of Digital Health Innovation in Asia Pacific, explores challenges, priorities and potential collaboration pathways in digital health from the perspective of over 700 professionals in the ecosystem from three main groups — healthcare and life sciences organizations, technology companies and investors. 

Click here to access the report.

Author

Elisabeth White is a partner in Baker McKenzie's Sydney office. Elisabeth has over 15 years' experience as an intellectual property and regulatory advisor, focusing upon IP protection and enforcement with a particular emphasis on regulated industries and related disputes. Elisabeth is described in Asia Pacific Legal 500 as providing “decisive expert opinion and a pragmatic approach”. She has been featured in Best Lawyers - Intellectual Property listed annually since 2013.

Author

Vanina Caniza is a partner in Baker McKenzie’s Buenos Aires office and the Global Chair of the Healthcare & Life Sciences Group. She advises a range of multinational, Latin America and Argentine clients in a variety of corporate and commercial law matters, with extensive experience in corporate compliance, commercial agreements, mergers & acquisitions and regulatory advice. Vanina has extensive knowledge in the pharmaceutical, biotech and medical device sectors.